Search Results - "Matusevicius, Darius"
-
1
Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit–The EU Regulator's Perspective
Published in Frontiers in medicine (27-08-2021)“…Since the implementation of the EU Orphan Regulation in 2000, the Committee for Orphan Medicinal Products at the European Medicines Agency has been evaluating…”
Get full text
Journal Article -
2
Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation
Published in Gene therapy (01-07-2024)“…Adoptive cell therapy (ACT), particularly chimeric antigen receptor (CAR)-T cell therapy, has emerged as a promising approach for targeting and treating rare…”
Get full text
Journal Article -
3
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Published in Journal of proteomics (2010)“…Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that results in damage to myelin sheaths and axons in the central nervous system…”
Get full text
Journal Article Conference Proceeding -
4
Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA
Published in Stroke (1970) (01-02-1998)“…Ischemic brain injury secondary to an arterial occlusion is characterized by acute local inflammation. Blood polymorphonuclear leukocytes (PMNL), primarily…”
Get full text
Journal Article -
5
Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis
Published in Clinical immunology (Orlando, Fla.) (01-02-2003)“…Multiple sclerosis has been postulated to be an autoimmune disease in which Th1 immune responses predominate. This response is associated with an increased…”
Get full text
Journal Article -
6
High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases
Published in European journal of neurology (01-07-1999)“…Ischemic stroke is associated with altered systemic immune responses both early after the onset and in the recovery phase. Interleukin (IL)‐10, a Th2 related…”
Get full text
Journal Article -
7
γ/δ T Cells in Multiple Sclerosis: Chemokine and Chemokine Receptor Expression
Published in Clinical immunology (Orlando, Fla.) (01-06-2002)“…γ/δ T cells are enriched in multiple sclerosis (MS) brain lesions and have been postulated to contribute to the pathogenesis of the disease. Increased…”
Get full text
Journal Article -
8
Metalloproteinases and their Tissue Inhibitors in Multiple Sclerosis
Published in Journal of autoimmunity (01-06-1999)“…Matrix metalloproteinases (MMPs) comprise a family of proteolytic enzymes. MMPs are capable of disrupting the blood-brain barrier (BBB), mediating the…”
Get full text
Journal Article -
9
Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis
Published in European journal of immunology (01-11-1998)“…The interactions of CD28‐B7 and CD40‐CD40 ligand (CD40L) pathways in T cell co‐stimulation and autoimmune disease are incompletely understood. We sought to…”
Get full text
Journal Article -
10
Tumor necrosis factor-α, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis
Published in Journal of neuroimmunology (01-12-1996)“…Myasthenia gravis (MG) is a neuromuscular disorder mediated by autoantibodies against the nicotinic acetylcholine receptor (AChR) on the postsynaptic membrane…”
Get full text
Journal Article -
11
Altered expression of costimulatory molecules in myasthenia gravis
Published in Muscle & nerve (01-06-2000)“…To characterize the involvement of costimulatory pathways in the pathogenesis of myasthenia gravis (MG), a multiparameter flow cytometry assay was adopted to…”
Get full text
Journal Article -
12
The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis
Published in Clinical neuropharmacology (01-07-1998)“…The inflammatory nature of multiple sclerosis (MS) implicates the participation of cytokines as immune response mediators. Targeting the cytokine balance by…”
Get more information
Journal Article -
13
No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis
Published in Journal of neuroimmunology (02-11-1998)“…The perivascular accumulation of mononuclear cells (MNC) in brain white matter is critical in the development of active lesions in multiple sclerosis (MS)…”
Get full text
Journal Article